丹参通脉胶囊对心肌缺血心电图的影响
稳心颗粒联合西药治疗阵发性心房颤动
84例疗效观察
Curative effect observation of Wenxin Granule combinedwith amiodarone
in treating 84 cases of paroxysmal atrial fibrillation
张荣珍
（濮阳市中医院，河南 濮阳，457001）
中图分类号：R256.12 文献标识码：A 文章编号：1674-7860（2016）15-0037-03 证型：BGA
【摘 要】目的：探讨心房颤动（房颤）患者应用稳心颗粒联合胺碘酮的临床疗效及安全性。方法：选取我院收治的急性房颤患者84例为临床研究对象，将其随机分成治疗组42例，对照组42例。对照组常规给予胺碘酮，治疗组应用稳心颗粒联合胺碘酮治疗，比较两组心房颤动改善情况及不良反应发生率。结果：治疗6个月后，观察组总有效率明显高于对照组，差异均有统计学意义（P＜0.05）。观察组治疗期间不良反应发生率明显低于对照组（P＜0.05）。结论：稳心颗粒联合胺碘酮治疗阵发性房颤临床疗效满意，具有良好的安全性。
【关键词】稳心颗粒；胺碘酮；心房颤动
【Abstract】Objective: To investigate the clinical efficacy andsafety of application of Wenxin Granule combined with amiodarone in treating patientswith atrial fibrillation (AF). Methods: 84 patients with acute atrialfibrillation admitted to our hospital were selected and randomly divided intothe treatment group (42 cases) and the control group (42 cases), the controlgroup was treated with amiodarone while the treatment group received WenxinGranule combined with amiodarone, the atrial fibrillation improvement andincidence of adverse reactions of two groups were compared. Results:6 months after treatment, the totaleffective rate of the observation group was significantly higher than that ofthe control group, the differences were statistically significant (P<0.05). The incidence of adversereactions of the observation group was significantly lower than that of thecontrol group (P<0.05).Conclusion:The efficacy of Wenxin Granule combined with amiodarone wassatisfactory in treating patients with atrial fibrillation and it was with goodsafety.
【Keywords】Wenxin Granule; Amiodarone; Atrial fibrillation
doi:10.3969/j.issn.1674-7860.2016.15.018
参考文献：
[1]徐红娟,郭燕.稳心颗粒与普罗帕酮治疗早搏的疗效比较[J].中国实验方剂学杂志,2013,1(10):304-307.
[2]陈吉丽,马娟,王玮,等.阵发性心房颤动发生的相关研究进展[J].心血管病学进展,2010,31(1):116-119.
[3]程吉东.稳心颗粒治疗阵发性心房颤动临床观察[J].中国中医药信息杂志,2007,14(8):55-56.
[4]吕娜,林玎,林萍.稳心颗粒联合小剂量胺碘酮治疗老年阵发性房颤60例疗效观察[J].福建中医药,2010,41(3):7-8.
[5]Ruigómez A,Johansson S,WallanderM A,et al. Predictors and prognosis ofparoxysmal atrial fibrillation in general practice in the UK[J].BMC CardiovascDisord,2005,5(1):20.
[6]Kerr C R.Humphries K H.TalajicM.et al. Progression to chronic atrialfibrillation after the initial diagnosis of paroxysmal atrial fibrillation：results from the Canadian Registry of AtrialFibrillation[J]. Am Heart J,2005,149(3):489-496.
[7]胡海东.持续性房颤与阵发性房颤发生急性缺血性脑卒中的临床风险比较[J].海南医学,2012,68(21):8452-8453.
[6]王旭渤,于水.P波离散度与阵发性心房纤颤的关系[J].中国实验诊断学,2004,8(2):171-172.
[7]Dilaveris P E,Gialafos E J,SiderisS K,et al.Simple electrocardiographic markersfor the prediction of paroxysmal idiopathic atrial fibrillation[J].Am Heart J,1998,135(5):733-738.
[8]赵宏,张宏宇.小剂量丙基硫氧嘧啶联合普萘洛尔治疗亚临床甲亢合并阵发性房颤临床疗效观察[J].实用临床医药杂志,2012,64(11):562-563.
[9]高晓,姜绍连,冯建设,等.步长稳心颗粒治疗阵发性心房颤动70]例[J].世界中医药,2009,4(增刊):53-54.
[10]郭继鸿.稳心颗粒:国际研究最新进展[J].临床心电学杂志,2015(1):251-64.
作者简介：
张荣珍（1971-），副主任医师，汉族，研究方向：内科
 |
